Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
TVM Capital Life Science Announces Substantially Oversubscribed US$478 Million Final Closing of TVM Life Science Innovation II, largest fund in the firm's history 2020-10-27 20:00
Sihuan Pharmaceutical (0460.HK) receives approval for its exclusive medical aesthetic product Letybo (botulinum toxin), A blockbuster product in a hundred-billion size market 2020-10-27 10:42
Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study 2020-10-27 10:03
Ascentage Pharma Announces Approval for the Phase Ib/II Clinical Study of MDM2-p53 Inhibitor APG-115 in Combination with Immunotherapy for the Treatment of Patients with Advanced Liposarcoma or other Advanced Solid Tumors in China 2020-10-27 08:13
CStone and EQRx Enter Global Strategic Partnership for Two Immune Checkpoint Inhibitors: sugemalimab (anti-PD-L1) and CS1003 (anti-PD-1) 2020-10-27 07:23
GMAX Biopharm gives first does of anti-body drug treating PAH in phase 1B trial 2020-10-26 18:00
Sai Life Sciences to significantly expand biology capabilities at its integrated R&D campus 2020-10-26 16:35
RhoVac Participates in BIO Europe Digital 2020-10-26 16:26
Article on RhoVac's Phase I/II study to be published in November 2020-10-26 15:51
/C O R R E C T I O N -- Azura Ophthalmics/ 2020-10-23 07:16
FDA Awards $1.1M Contract to CUBRC and EpiVax for Validation of New Immunoinformatic Tool for Prospective Immunogenicity Assessment of Peptide Drugs and Their Impurities 2020-10-22 21:00
Connect Biopharma to Present Additional Positive Results from the Phase 1b Study of CBP-201 for Patients with Moderate-to-Severe Atopic Dermatitis (AD) at EADV Virtual Meeting 2020-10-22 19:30
Sihuan Pharmaceutical's Gabapentin Capsules was Granted Drug Production Approval, the Third Company Obtained Approval in China 2020-10-22 10:36
Priority Review Granted to Ascentage Pharma's New Drug Application for Olverembatinib (HQP1351), the First Third-Generation BCR-ABL Inhibitor in China 2020-10-21 17:37
Cyclica to use Excelra's GOSTAR Database to develop AI & ML based Deep Learning Algorithm for Drug Target Identification 2020-10-21 10:00
One broken bone leads to another, warns IOF on World Osteoporosis Day 2020-10-21 06:18
Nanoform initiates GMP campaign for first-in-human trial of nanoformed drug by year end - ahead of schedule 2020-10-21 02:14
Key patent granted for Isla101 in Brazil 2020-10-20 03:15
Over One Thousand Psychiatrists Gather Online for Second Asia Pacific Psychiatry Symposium 2020-10-19 17:46
Xinhua Silk Road: The 51st Zhangshu National TCM Materials and Pharmaceuticals Trade Fair kicked off in the eastern Chinese city of Zhangshu 2020-10-19 17:41
1 277 278 279 280 281 413